← Back to Search

Dietary Supplement

Nutritional Ketogenic Supplement for Migraine (KEMIP Trial)

N/A
Waitlist Available
Led By Ginette Girard, MD
Research Sponsored by Société des Produits Nestlé (SPN)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 months
Awards & highlights

KEMIP Trial Summary

This trial found that a nutritional ketogenic supplement may help reduce the number, intensity, and duration of migraine headaches in people with episodic migraines.

Eligible Conditions
  • Migraine

KEMIP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean change from baseline in MDM versus placebo
Secondary outcome measures
Incidence, severity and relatedness of adverse events
Mean change from baseline in migraine intensity measured with a numerical rating scale from 1 to 10;
Mean change from baseline in the average migraine duration
+3 more

KEMIP Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active intervention (one month)Experimental Treatment1 Intervention
Nutritional Ketogenic Supplement (NKS) 2 x 12 g of EKS/day
Group II: Placebo (one month)Placebo Group1 Intervention
Isocaloric placebo supplement
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nutritional Ketogenic Supplement
2021
N/A
~60

Find a Location

Who is running the clinical trial?

Société des Produits Nestlé (SPN)Lead Sponsor
337 Previous Clinical Trials
62,511 Total Patients Enrolled
Diex Research Sherbrooke Inc.UNKNOWN
Healint Pte LtdUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Ketone for Migraine Prevention
2021. "Ketone for Migraine Prevention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05085483.
~15 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top